Oleg Gluz, MD | Authors

Multigene Testing to Forgo Chemotherapy in Early Breast Cancer

April 25, 2016

In this interview we discuss results of the PlanB trial, which showed that use of the 21-gene recurrence score, Oncotype DX, can identify patients with early breast cancer who likely do not need chemotherapy.